TILL TRANSAKTIONER
Hälsovård

InNeuroCo has been acquired by Integer

The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).

Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.

With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.

Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).

Uppdrag
Företagsförsäljning
Parter
“InNeuroCo’s founders have enjoyed a long-standing history of success with the Oaklins TM healthcare team. When we began contemplating a transaction for InNeuroCo, it was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate the team’s tireless dedication and thoughtful approach.”

Marc Litzenberg

President and CEO, InNeuroCo

Prata med transaktionsteamet

James McLaren

James McLaren

Managing Director
New York, USA
Oaklins TM Capital
Se profil Kontakta oss
Michael S. Goldman

Michael S. Goldman

Managing Director
New York, USA
Oaklins TM Capital
Se profil Kontakta oss
John Dean

John Dean

Associate Director
Atlanta, USA
Oaklins TM Capital
Se profil Kontakta oss
Bradley S. Goldstein

Bradley S. Goldstein

Associate Director
Atlanta, USA
Oaklins TM Capital
Se profil Kontakta oss
Ariel Fieldman

Ariel Fieldman

Associate
New York, USA
Oaklins TM Capital
Se profil Kontakta oss
Matthew Halbig

Matthew Halbig

Analyst
Atlanta, USA
Oaklins TM Capital
Se profil Kontakta oss

Relaterade transaktioner

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Riskkapital | Hälsovård

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Lär dig mer
Phen’X Technologies has sold a majority stake to Ciclad
Riskkapital | Hälsovård | Industriella maskiner och komponenter

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Lär dig mer
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Hälsovård | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Lär dig mer